Gabelli Funds’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History

Gabelli Funds’s Portfolio CBMG Stock Details CBMG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-64,143	Closed	-$1.18M	–	1449
2020 Q4	$1.18M	Buy	+64,143	New	+$1.17M	0.01%	839

Gabelli Funds's CBMG Position: Q1 2021 in Review

Gabelli Funds sold out of Cellular Biomedicine Group, Inc. (CBMG) in Q1 2021, closing a stake of 64,143 shares — an estimated $1.18M sold.

Gabelli Funds first reported a position in CBMG in Q4 2020 and held it in 1 quarter. The position peaked at $1.18M in Q4 2020. 0 funds tracked by Wall St. Rank hold CBMG as of Q1 2021.

Gabelli Funds reported no remaining Cellular Biomedicine Group, Inc. position as of Q1 2021 after selling out during the quarter.
Gabelli Funds sold 64,143 Cellular Biomedicine Group, Inc. shares in Q1 2021, an estimated $1.18M.
Gabelli Funds first reported a position in Cellular Biomedicine Group, Inc. in Q4 2020 and held it in 1 quarter.
Gabelli Funds's Cellular Biomedicine Group, Inc. position peaked at $1.18M in Q4 2020.
0 funds tracked by Wall St. Rank held Cellular Biomedicine Group, Inc. as of Q1 2021.

Based on Gabelli Funds's 13F filing for Q1 2021, filed 14 May 2021.